Kwong T C, Fitzpatrick P G, Rothbard R L
Clin Chem. 1984 May;30(5):731-4.
Enzyme kinetics for creatine kinase (CK), CK-MB, aspartate aminotransferase (AST), and lactate dehydrogenase (LD) in serum were followed in 14 patients who had suffered acute myocardial infarction and who were given intracoronary streptokinase shortly (mean 4.9 h, SD 2.6 h) after onset of symptoms. In the 10 patients for whom thrombolysis was successful, CK activity peaked earlier (12.8 vs 21.6 h) and at higher values (3548 vs 2436 U/L) than in the four patients for whom the treatment was unsuccessful. The mean maximum rate of increase in CK was threefold greater in the former group (574 vs 169 U/L per hour), but the total amount of CK released into the circulation and the fractional disappearance rates were similar for both groups. The profiles for AST and CK-MB for successfully treated patients closely resembled those for CK. LD, however, peaked significantly later than CK (25.7 vs 12.8 h). Early peaking of CK or CK-MB after nonsurgical reperfusion can be potentially useful as a noninvasive in vitro index to the success of therapy of myocardial infarction with thrombolytic agents.
对14例急性心肌梗死患者进行了研究,这些患者在症状发作后不久(平均4.9小时,标准差2.6小时)接受了冠状动脉内链激酶治疗,同时跟踪了血清中肌酸激酶(CK)、肌酸激酶同工酶(CK-MB)、天冬氨酸转氨酶(AST)和乳酸脱氢酶(LD)的酶动力学。在10例溶栓成功的患者中,CK活性达到峰值的时间更早(12.8小时对21.6小时),峰值也更高(3548 U/L对2436 U/L),高于4例治疗未成功的患者。前一组中CK平均最大升高速率是后一组的三倍(每小时574 U/L对169 U/L),但两组中释放到循环中的CK总量和分数消失率相似。成功治疗患者的AST和CK-MB曲线与CK的曲线非常相似。然而,LD达到峰值的时间明显晚于CK(25.7小时对12.8小时)。非手术再灌注后CK或CK-MB的早期峰值可能作为一种非侵入性体外指标,用于评估溶栓药物治疗心肌梗死的成功与否。